pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·3h ago·1 min read
save

Massachusetts offers $40M in tax incentives to spur 1,600+ life-science jobs

Sep 30, 2026·read at BioSpace ↗RegulatoryPositive

Massachusetts announced $40 million in tax incentives for 38 life‑science companies, targeting the creation of about 1,644 new jobs.

Most of the companies-31 of them-will expand outside Boston and Cambridge, representing roughly 71% of the positions, while Boston and Cambridge each expect over 200 jobs.

Recipients include AstraZeneca, Bristol Myers Squibb and Insulet. Four firms are receiving more than $1 million, and the largest award of $10 million goes to Insulet for 250 jobs in Acton.

The top five locations for new jobs are Cambridge (262), Acton (250), Waltham (212), Boston (207) and Devens (179). Companies must add and retain the positions through Dec 31 2028.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “$40M in tax incentives expected to generate 1,600+ life sciences jobs in Massachusetts”

read at BioSpace ↗
458 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECA4BRISTOL4BRISTOL MYERS SQUIBB4BRISTOL MYERS SQUIBB CO4
topics
Medical Device Company2

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: AnaCardio adds $71M ; Breye bags $76.5MFierce Biotech
  • Aug 3An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.BioPharma Dive
  • Aug 3Supernus and Indivior merge to create CNS mega-company with 11 approved drugsBioSpace
  • Aug 3STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and moreSTAT
  • Aug 3‘Unlikely’ AstraZeneca-BMS mega-merger would be largest pharma deal everBioSpace